S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea · Delayed Price · Currency is KRW 19,790
+790 (4.16%)
At close: Aug 20, 2026
S.Biomedics Market Cap
S.Biomedics has a market cap or net worth of 245.1 billion as of August 20, 2026. Its market cap has increased by 3.75% in one year.
Market Cap
245.10B
Enterprise Value
255.62B
Revenue
16.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
19,790.00
ChartMarket Cap Chart
Since May 4, 2023, S.Biomedics's market cap has increased from 206.56B to 245.10B, an increase of 18.66%. That is a compound annual growth rate of 5.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 245.10B | -45.95% |
| Dec 30, 2025 | 453.47B | 123.16% |
| Dec 30, 2024 | 203.20B | 55.86% |
| Dec 28, 2023 | 130.38B | -36.88% |
| May 4, 2023 | 206.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curocell | 376.11B |
| IntoCell | 307.20B |
| HansBiomed | 271.82B |
| IMBiologics | 250.04B |
| curacle co.,ltd. | 232.00B |
| Kangstem Biotech | 224.32B |
| Genome & Company | 221.23B |
| Kanaph Therapeutics | 194.82B |